Search

Author/Creator Chowdhury, Simon

21. Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial. Issue 12 (December 2020)

Authors:
Powles, Thomas; van der Heijden, Michiel S; Castellano, Daniel; Galsky, Matthew D; Loriot, Yohann; Petrylak, Daniel P; Ogawa, Osamu; Park, Se Hoon; Lee, Jae-Lyun; De Giorgi, Ugo; Bögemann, Martin; Bamias, Aristotelis; Eigl, Bernhard J; Gurney, Howard; Mukherjee, Som D; Fradet, Yves; Skoneczna, Iw...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 12(2020)
Page Start:
1574
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

22. Effect of enzalutamide on health-related quality of life, pain, and skeletal-related events in asymptomatic and minimally symptomatic, chemotherapy-naive patients with metastatic castration-resistant prostate cancer (PREVAIL): results from a randomised, phase 3 trial. Issue 5 (May 2015)

Authors:
Loriot, Yohann; Miller, Kurt; Sternberg, Cora N; Fizazi, Karim; De Bono, Johann S; Chowdhury, Simon; Higano, Celestia S; Noonberg, Sarah; Holmstrom, Stefan; Mansbach, Harry; Perabo, Frank G; Phung, De; Ivanescu, Cristina; Skaltsa, Konstantina; Beer, Tomasz M; Tombal, Bertrand
Journal:
Lancet oncology
Issue:
Volume 16:Issue 5(2015:May)
Page Start:
509
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

23. Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study. Issue 2 (February 2016)

Authors:
Shore, Neal D; Chowdhury, Simon; Villers, Arnauld; Klotz, Laurence; Siemens, D Robert; Phung, De; van Os, Steve; Hasabou, Nahla; Wang, Fong; Bhattacharya, Suman; Heidenreich, Axel
Journal:
Lancet oncology
Issue:
Volume 17:Issue 2(2016:Feb.)
Page Start:
153
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

24. Erratum to 'Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration-resistant prostate cancer: The CATS international database' [European Journal of Cancer, Volume 125 (January 2020) Pages 153–163]. (September 2020)

Authors:
Delanoy, Nicolas; Hardy-Bessard, Anne-Claire; Efstathiou, Eleni; Moulec, Sylvestre Le; Basso, Umberto; Birtle, Alison; Thomson, Alastair; Krainer, Michael; Guillot, Aline; Giorgi, Ugo De; Hasbini, Ali; Daugaard, Gedske; Bahl, Amit; Chowdhury, Simon; Caffo, Orazio; Beuzeboc, Philippe; Spaeth, Domi...
Journal:
European journal of cancer
Issue:
Volume 137(2020)
Page Start:
290
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

25. Final quality of life and safety data for patients with metastatic castration‐resistant prostate cancer treated with cabazitaxel in the UK Early Access Programme (EAP) (NCT01254279). (16th June 2015)

Authors:
Bahl, Amit; Masson, Susan; Malik, Zafar; Birtle, Alison J.; Sundar, Santhanam; Jones, Rob J.; James, Nicholas D.; Mason, Malcolm D.; Kumar, Satish; Bottomley, David; Lydon, Anna; Chowdhury, Simon; Wylie, James; de Bono, Johann S.
Journal:
BJU international
Issue:
Volume 116:Number 6(2015:Dec.)
Page Start:
880
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

26. Graham Roberts Study protocol: first 'trials within cohort study' for bladder cancer. Issue 9 (26th September 2019)

Authors:
Wylie, Harriet; Cahill, Fidelma; Santaolalla, Aida; Moss, Charlotte Louise; Enting, Deborah; Amery, Suzanne; Chatterton, Kathryn; Khan, Muhammad Shamim; Bryan, Richard T; Gillett, Cheryl; Josephs, Debra; Chowdhury, Simon; Rudman, Sarah; Hughes, Simon; Relton, Clare; Van Hemelrijck, Mieke
Journal:
BMJ open
Issue:
Volume 9:Issue 9(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

27. Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study. Issue 11 (November 2019)

Authors:
Agarwal, Neeraj; McQuarrie, Kelly; Bjartell, Anders; Chowdhury, Simon; Pereira de Santana Gomes, Andrea J; Chung, Byung Ha; Özgüroğlu, Mustafa; Juárez Soto, Álvaro; Merseburger, Axel S; Uemura, Hirotsugu; Ye, Dingwei; Given, Robert; Cella, David; Basch, Ethan; Miladinovic, Branko; Dearden, Lindsa...
Journal:
Lancet oncology
Issue:
Volume 20:Issue 11(2019)
Page Start:
1518
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

28. Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP. Issue 8 (10th March 2022)

Authors:
Stockler, Martin R.; Martin, Andrew J.; Davis, Ian D.; Dhillon, Haryana M.; Begbie, Stephen D.; Chi, Kim N.; Chowdhury, Simon; Coskinas, Xanthi; Frydenberg, Mark; Hague, Wendy E.; Horvath, Lisa G.; Joshua, Anthony M.; Lawrence, Nicola J.; Marx, Gavin M.; McCaffrey, John; McDermott, Ray; McJannett...
Journal:
Journal of clinical oncology
Issue:
Volume 40:Issue 8(2022)
Page Start:
837
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗